Bio-Techne
Price
Price
CHART BY
Historical dividends and forecast
Bio-Techne has so far distributed $0.32 in 2024. The next dividend will be paid on 26.02.2025
CHART BY
Frequently asked questions
What is Bio-Techne's market capitalization?
What is Bio-Techne's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Bio-Techne?
What are the analyst ratings and target price for Bio-Techne's stock?
What is Bio-Techne's revenue over the trailing twelve months?
What is the EBITDA for Bio-Techne?
What is the free cash flow of Bio-Techne?
How many employees does Bio-Techne have, and what sector and industry does it belong to?
What is the free float of Bio-Techne's shares?
Financials
- Market Cap
- $11.63B
- EPS (TTM)
- $0.938
- Free Float
- 157.23M
- P/E ratio (TTM)
- 77.98
- Revenue (TTM)
- $1.17B
- EBITDA (TTM)
- $355.97M
- Free Cashflow (TTM)
- $245.03M
Pricing
- 1D span
- $70.15$74.43
- 52W span
- $61.17$85.51
Analyst Ratings
The price target is $85.42 and the stock is covered by 17 analysts.
Buy
13
Hold
4
Sell
0
Information
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
- Employees
- 3,100
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US09073M1045
- Primary Ticker
- TECH